---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-062492"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T04:41:04.908849+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inogen names Kevin Smith President and CEO; new compensation includes $1.7M sign-on bonus

## Summary
- Kevin Smith appointed President and CEO effective Nov 10, 2023, succeeding Nabil Shabshab who departed same day.
- Smith brings over 20 years med-device leadership, most recently CEO of Sirtex Medical.
- Compensation: $700K salary, 100% target bonus, $1.7M sign-on bonus (two installments), 170K equity (RSUs + PSUs).
- Full-year 2023 financial guidance reaffirmed; company will skip Stifel and Piper Sandler conferences.

## SEC filing metadata
- accession: 0000950170-23-062492
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/ingn-20231110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-062492
- JSON: https://secwatch.observer/filing/0000950170-23-062492.json
- Plain text: https://secwatch.observer/filing/0000950170-23-062492.txt

## Key facts
- Executive change
  Kevin Smith was appointed as Class III director at Inogen Inc.
  - Action: appointed
  - Role: Class III director
  source text: appointed Mr. Smith to serve as a Class III director of the Company, effective November 10, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm
- Executive change
  Kevin Smith was appointed as President and Chief Executive Officer at Inogen Inc.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: appointed Kevin Smith to serve as President and Chief Executive Officer ("CEO") of the Company, effective November 10, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm
- Executive change
  Nabil Shabshab departed as President and Chief Executive Officer at Inogen Inc.
  - Action: ended
  - Role: President and Chief Executive Officer
  source text: Mr. Shabshab's role as an officer and employee of the Company ended effective November 10, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.